FDA Approved: EUCRISA — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved EUCRISA (crisaborole) in its original NDA, establishing the topical PDE-4 inhibitor as a treatment for atopic dermatitis. The approval was issued t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Eucrisa (crisaborole)

Snippet

ORIG AP for EUCRISA (CRISABOROLE)